Health and Healthcare

Mesoblast : MESO

MESO

Stock Data

$15.74

$0.07 (0.45%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

Mesoblast Limited, a biopharmaceutical company, develops and markets allogeneic cellular drugs. The company is headquartered in Melbourne, Australia.

All Mesoblast Articles

2 Articles

Chris Lange | Apr 24, 2020 at 10:50 AM EDT

Is This Mesoblast Move Overrated?

Mesoblast shares more than doubled on Friday after the company provided an update on its COVID-19 treatment. Should it be…

Chris Lange | Mar 10, 2020 at 11:10 AM EDT

Coronavirus Stocks Seeing the Biggest Bounce Back

More and more companies are joining the fight against the coronavirus, and 24/7 Wall St. is taking a look at…